Return to: Department of Pediatrics : Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Division of Pediatrics and Clinical Research, Department of Pediatrics
Whats Inside
Research

Education

Faculty and Staff

Contact Us

 

Peds Epi Home



University Pediatrics Foundation - Make a Gift

Viking Children's Fund

Children's Cancer Research Fund

Department of Pediatrics > Epidemiology > Faculty and Staff > Aaron S. Kelly, Ph.D. > Invited Talks & Presentations

Printer-friendly version   Mail this page to a friend

Invited Talks & Presentations


"Childhood obesity and cardiovascular disease - what's the big deal?"  Grand Rounds and Research Day, St. Paul Heart Clinic, St. Paul, MN (Sep 2003)

"The role of exercise and weight loss in decreasing cardiovascular risk."  Grand Rounds and Research Day, St. Paul Heart Clinic, St. Paul, MN (Sep 2004)

"The role of exercise and weight loss in decreasing cardiovascular risk."  Cardiovascular and Pulmonary Rehabilitation Conference, United's John Nasseff Heart Hospital, St. Paul, MN (Apr 2005)

"Type 2 diabetes, cardiovascular disease, and the thiazolidinediones."  Columbia Park Medical Group, Brooklyn Park, MN (Jan 2006)

"Type 2 diabetes, cardiovascular disease, and the thiazolidinediones."  Northwest Family Physicians, Plymouth, MN (Jan 2006)

"Role of exercise to prevent and control heart disease and diabetes."  Mended Hearts Group, St. Paul, MN (Feb 2006)

“Type 2 diabetes, cardiovascular disease, and the thiazolidinediones.”  Mankato Clinic, Mankato, MN (Mar 2006)

“Type 2 diabetes, cardiovascular disease, and the thiazolidinediones.”  Chisago City, MN (Apr 2006)

"Type 2 diabetes, cardiovascular disease, and the thiazolidinediones.”  St. Mary’s Duluth Clinic, Hayward, WI (Apr 2006)

“Type 2 diabetes, cardiovascular disease, and the thiazolidinediones.”  Columbia Park Medical Group, Brooklyn Park, MN (Jun 2006)

“Diabetes and heart disease.”  Lakeview Hospital, Stillwater, MN (Aug 2006)

“Conducting high quality and ethical investigator-initiated trials.”  University of Minnesota, Minneapolis, MN (Aug 2006)

“Type 2 diabetes, cardiovascular disease, and the thiazolidinediones.”  Apple Valley Medical Center, St. Paul, MN (Nov 2006)

“Early primary prevention of cardiovascular disease: evaluating risk in children.” Graduate Research Seminar, School of Kinesiology, University of Minnesota, Minneapolis, MN (Feb 2007)

“Early primary prevention of cardiovascular disease: evaluating risk in children.” Pediatric Grand Rounds, University of Minnesota, Minneapolis, MN (Feb 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Columbia Park Medical Group – Brooklyn Park, Minneapolis, MN (Apr 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Columbia Park Medical Group – Columbia Heights, Columbia Heights, MN (Apr 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Fairview EdenCenter Clinic, Eden Prairie, MN (Apr 2007)

"Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones."  Chaska Crossroads Clinic, Chaska, MN (May 2007)

“Diabetes and heart disease: what you need to know.”  Insulin Pump Support Group, St. John’s Hospital, Maplewood, MN (May 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Minneapolis Endocrinology Clinic, Edina, MN (Jun 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Hudson Physicians-Western Wisconsin Medical Associates, Hudson, WI (Jul 2007)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Minn Health Clinic, Maplewood, MN (Oct 2007)

“Primary prevention of cardiovascular disease – detecting and treating endothelial activation in children.”  Seminar, Division of Pediatric Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN (Nov 2007)

"Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones."  Sanford Health, Sioux Falls, SD (Feb 2008)

“Pediatric obesity and cardiovascular risk.”  Pediatric/Adolescent Potpourri (Sponsored by St. Cloud Hospital), Breezy Point, MN (Feb 2008)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  Consultants Internal Medicine, Edina, MN (Mar 2008)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  North Memorial Golden Valley Clinic, Golden Valley, MN (Apr 2008)

“Type 2 diabetes, visceral adiposity, and insulin resistance: role of the thiazolidinediones.”  North Memorial Brooklyn Park Clinic, Brooklyn Park, MN (May 2008)


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.